Literature DB >> 29275384

Cutaneous infection with paucibacillary Mycobacterium tuberculosis treated successfully with a modified antituberculous drug regimen.

Nicholas Laidler1.   

Abstract

Tuberculosis is a serious infection that is increasing in prevalence, affecting many people worldwide. The diagnosis of cutaneous tuberculosis is challenging and requires the correlation of clinical findings with often inconclusive diagnostic testing. Extrapulmonary tuberculosis comprises approximately 10% of all cases of tuberculosis, and cutaneous tuberculosis makes up only a small proportion of these cases. Discussed here is the case of a 61-year-old immunocompetent female with a large cutaneous lesion on her index finger secondary to Mycobacterium tuberculosis Tissue cultures taken at biopsy were negative; however, empiric antimycobacterial therapy was initiated. The initial regimen was not tolerated, and antituberculous therapy was substituted for moxifloxacin and clarithromycin. The lesion improved significantly with a concurrent improvement in function. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Tb and other respiratory infections; dermatology; drug interactions; infections; skin

Mesh:

Substances:

Year:  2017        PMID: 29275384      PMCID: PMC5780583          DOI: 10.1136/bcr-2017-221938

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Short course monotherapy with clarithromycin for localized Mycobacterium marinum skin infection.

Authors:  M R Weinstein; D E Low; T Mazzulli
Journal:  Can J Infect Dis       Date:  1997-05

2.  Cutaneous tuberculosis: a practical case report and review for the dermatologist.

Authors:  Amylynne Frankel; Carolin Penrose; Jason Emer
Journal:  J Clin Aesthet Dermatol       Date:  2009-10

3.  Cutaneous manifestations of tuberculosis.

Authors:  J E Lai-Cheong; A Perez; V Tang; A Martinez; V Hill; H du P Menagé
Journal:  Clin Exp Dermatol       Date:  2007-03-21       Impact factor: 3.470

4.  Cutaneous tuberculosis in Morocco.

Authors:  Kawtar Zouhair; Nadia Akhdari; Fatima Nejjam; Tam Ouazzani; Hakima Lakhdar
Journal:  Int J Infect Dis       Date:  2006-07-05       Impact factor: 3.623

5.  How soon does cutaneous tuberculosis respond to treatment? Implications for a therapeutic test of diagnosis.

Authors:  M Ramam; Rashmi Mittal; V Ramesh
Journal:  Int J Dermatol       Date:  2005-02       Impact factor: 2.736

Review 6.  Cutaneous tuberculosis.

Authors:  Francisco G Bravo; Eduardo Gotuzzo
Journal:  Clin Dermatol       Date:  2007 Mar-Apr       Impact factor: 3.541

Review 7.  Cutaneous tuberculosis overview and current treatment regimens.

Authors:  Lindi van Zyl; Jeanetta du Plessis; Joe Viljoen
Journal:  Tuberculosis (Edinb)       Date:  2014-12-25       Impact factor: 3.131

8.  Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.

Authors:  Marcus B Conde; Anne Efron; Carla Loredo; Gilvan R Muzy De Souza; Nadja P Graça; Michelle C Cezar; Malathi Ram; Mohammad A Chaudhary; William R Bishai; Afranio L Kritski; Richard E Chaisson
Journal:  Lancet       Date:  2009-04-04       Impact factor: 79.321

Review 9.  Cutaneous tuberculosis: diagnosis and treatment.

Authors:  Joseph Barbagallo; Patricia Tager; Rosemary Ingleton; Ranella J Hirsch; Jeffrey M Weinberg
Journal:  Am J Clin Dermatol       Date:  2002       Impact factor: 7.403

Review 10.  Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects - part I.

Authors:  Josemir Belo Dos Santos; Ana Roberta Figueiredo; Cláudia Elise Ferraz; Márcia Helena de Oliveira; Perla Gomes da Silva; Vanessa Lucília Silveira de Medeiros
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.